Cancer Network spoke with Kathryn Cecilia Arbour, MD, of Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in oncology.
Kathryn Cecilia Arbour, MD
Advertisement
Articles by Kathryn Cecilia Arbour, MD
Advertisement
Latest Updated Articles
Dr. Arbour on the Latest Data for Checkpoint Inhibitors for Lung Cancer in 2019Published: June 11th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Raludotatug Deruxtecan Shows Promise in Platinum-Resistant Ovarian Cancer
2
Patient With RRMM, Cytopenias, COPD, and Progressive Bone Disease
3
FDA Accepts Resubmission of BLA for RP1/Nivolumab in Advanced Melanoma
4
Why is Radiotherapy Not More Accessible as a Cancer Treatment?
5
